Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

C026 - Advanced Self-assessment of Dermatopathology

Monday, February 19; 9:00 AM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Analyze 50 unknown dermatopathology cases of advanced complexity via independent microscopic examination.
  • Formulate an appropriate differential diagnosis based on the clinical information provided and path analysis.
  • Select the most appropriate diagnosis based upon the histopathologic features and clinical situation


This self-assessment course in dermatopathology is designed to allow participants to test their skills and knowledge base using actual examination of glass slides containing challenging diagnosis. The faculty is not able to give an all-inclusive review in this session, but important points in the microscopic differential diagnosis will be highlighted with regard to some advanced dermatopathology cases. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.


  • Ferringer, Tammie C., MD: no financial relationships exist with commercial interests.
  • Gerami, Pedram, MD: Castle Biosciences, Inc – C(H); DermTech International – C(H); Myriad Genetics Inc – C(H);
  • Guitart, Joan, MD: Actelion – I(Grants/Research Funding); Elorac, Inc. – I(Grants/Research Funding); Galderma Research & Development, LLC – I(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – A(Fees); miRagen Therapeutics, Inc. – I(Grants/Research Funding); Soligenix, Inc – I(Grants/Research Funding);
  • High, Whitney A., MD, JD: no financial relationships exist with commercial interests.
  • Piliang, Melissa, MD: Castle Biosciences – A(H); Eli Lilly and Company – I(NC); Incyte Corporation – I(NC); Kythera – I(NC); Procter & Gamble Company – C(H); Samumed, LLC – A(H);
  • Prieto, Victor G., MD, PhD: Myriad Genetic Laboratories – C(H);
  • Robinson-Bostom, Leslie, MD: no financial relationships exist with commercial interests.
  • Sangueza, Omar P., MD: no financial relationships exist with commercial interests.
  • Thompson, Curtis T., MD: no financial relationships exist with commercial interests.
  • Vandergriff, Travis W., MD: no financial relationships exist with commercial interests.
Monday, February 19
9:00 AM
/ Microscope Exam/Self-Assessment
1:00 PM
Dr. Ferringer / Case presentation 1-5
1:15 PM
Dr. Gerami / Case presentation 6-10
1:30 PM
Dr. High / Case presentation 11-15
1:45 PM
/ Catch-up, Break, & Questions
1:55 PM
Dr. Piliang / Case presentation 16-20
2:10 PM
Dr. Prieto / Case presentation 21-25
2:25 PM
Dr. Robinson-Bostom / Case presentation 26-30
2:40 PM
/ Catch-up, Break, & Questions
2:50 PM
Dr. Sangueza / Case presentation 31-35
3:05 PM
Dr. Thompson / Case presentation 36-40
3:20 PM
Dr. Vandergriff / Case presentation 41-45
3:35 PM
Dr. Guitart / Case presentation 46-50
3:50 PM
/ Final catch-up, questions, adjournment
Event Details
  • Date
    Monday, February 19
  • Time
    9:00 AM - 4:00 PM
  • Location
    Room 31B
  • CME Credits
  • Type
  • Joan Guitart, MD, FAAD
  • Curtis T. Thompson, MD
  • Leslie Robinson-Bostom, MD, FAAD
  • Melissa Piliang, MD, FAAD
  • Omar P. Sangueza, MD
  • Pedram Gerami, MD, FAAD
  • Tammie C. Ferringer, MD, FAAD
  • Travis W. Vandergriff, MD, FAAD
  • Victor G. Prieto, MD, PhD
  • Whitney A. High, MD, JD, FAAD